Moderna's greed has caused suffering across the world.

Profiteering is always a problem—especially when it happens on the public dime. The US government invested billions in Moderna’s vaccine technology, but Moderna has not shared the benefits with the public.

The company raked in almost $18 billion in profits in 2022 alone, while multiple shareholders, including CEO Stéphane Bancel, have become billionaires.

Meanwhile, it has stonewalled all efforts to share its publicly funded technology with the world or license out production to other manufacturers.Globally, millions of people have died unnecessarily because of a lack of access to COVID vaccines—and Moderna’s hoarding deserves much of the blame.

Moderna and Pfizer produced mRNA vaccines, a new, highly effective technology based on decades of publicly funded research. The mRNA technology is vital not just for fighting the many strains of COVID-19, but to prepare for new infectious diseases, and to treat existing maladies like malaria. The refusal to share mRNA technology will widen inequities in access to medicines for future pandemics, making us all less safe. Remember—viruses don’t care about borders.

That’s why the Afrigen Technology Transfer Hub in South Africa, backed by the World Health Organization, is working hard to make mRNA technology available worldwide. They will then open-source this technology and share it with partner manufacturers in dozens of countries—a truly transformative and lifesaving effort. By providing scientific and technical support, Moderna could make it so the Hub doesn’t have to reinvent the wheel, greatly accelerating their work and making the world a safer and healthier place.

Moderna’s collaboration would save precious time when it comes to life-saving medicines: not only the COVID vaccine, but future treatments for HIV, tuberculosis, malaria, and more. The success of the Hub would advance global health equity and access for all countries—Moderna’s refusal to support its work so far is not only greedy, it’s deadly.

Moderna must engage in technology transfer with the Afrigen Hub, and with companies across the Global South to ensure sustainable vaccine supply and access for countries. Sharing the science is essential: for our loved ones and global neighbors across the world, for ending the variants, for our elderly, for our families, for our communities.

Tell Moderna once and for all: share the science with the Afrigen Hub and companies across the Global South to ensure access to medicines and guarantee the human right to public health.